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Abstract 23 
The objective of this study was i) to quantify the risk of hepatitis E for Swiss consumers 24 
by  specified pork products and ii) to estimate the total burden of human food-borne 25 
hepatitis E in Switzerland. A quantitative risk assessment from slaughter to 26 
consumption was carried out according to the Codex Alimentarius framework. In the 27 
hazard characterization, assumptions were made due to the lack of a dose-response 28 
relationship for oral exposure to hepatitis E virus (HEV). The prevalence of HEV in 160 29 
pig livers of 40 different Swiss fattening farms was examined and determined to be 30 
1.3% (CI 0.3%; 4.4%). This result was used as input in the risk assessment model, 31 
together with data from other published studies.  The annual burden of hepatitis E was 32 
estimated in terms of Disability Adjusted Life Years (DALY), using data about hepatitis E 33 
cases diagnosed between 2010 and 2015 at two major hospitals located in the canton 34 
Ticino. Only the  risk of foodborne hepatitis E from products containing pork liver was 35 
evaluated, as those containing only pork meat could not be evaluated because  of lack 36 
of data on HEV load in pork. Assuming that successful oral infection occurs in 1% of 37 
servings contaminated with high HEV loads (>105 genome copies), and that acute 38 
illness develops in 5% of susceptible consumers,  the most likely annual number of 39 
foodborne hepatitis E cases in Switzerland was estimated to be 1,481 (95% CI 552; 40 
4,488) if all products containing pork liver were considered. If only high-risk products, 41 
such as plain pork liver and liver sausages (e.g. Saucisse au Foie), were considered, the 42 
annual number of cases was estimated to be 176 (95% CI 64; 498). We were unable to 43 
calculate the total burden of hepatitis E in Switzerland due to lack of data. Yet, for the 44 
canton Ticino, it was shown that a significant increase had occurred from <5 DALY per 45 
100,000 inhabitants before 2012 to >50 DALY per 100,000 inhabitants in 2015. This 46 
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change could partly be due to an increased reporting and higher awareness among 47 
medical practitioners. Extrapolation to other regions could be accomplished if detailed 48 
information on food consumption patterns were available. Notification of HEV cases 49 
and attempts of cases source attribution would improve the basis for risk assessments. 50 
 51 
Keywords 52 
Pork; genotype 3 HEV; microbiological risk assessment; DALY  53 
 54 
Highlights  55 
- The prevalence of HEV RNA detection in Swiss pig livers at slaughter is 1.3% 56 
(95% CI 0.3%; 4.4%) 57 
- The annual number of human hepatitis E cases due to high risk products was 58 
estimated as 176 (95% CI 64; 498) 59 
- The total burden due to Hepatitis E in the canton Ticino was >50 DALY per 60 
100,000 inhabitants in 2015   61 
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1. Introduction 62 
Hepatitis E virus (HEV) is a relatively recently discovered hepatotropic virus (Reyes et 63 
al., 1991). To date, four genotypes (GT) affecting humans have been identified; GT3, 64 
and to a lesser extent GT4 represent the most common genotypes found in 65 
industrialized countries (Dalton et al., 2013). The clinical presentation is 66 
indistinguishable from Hepatitis A with classical symptoms including jaundice, 67 
anorexia, abdominal pain accompanied by fever, nausea and vomiting (Emerson and 68 
Purcell, 2003). Hepatitis E is usually self-limiting, but chronic infections have been 69 
described in immune-depressed patients (Bihl and Negro, 2009) and organ transplant 70 
recipients (Arends et al., 2014; Kamar et al., 2012). Fulminant and fatal HEV GT3 cases 71 
have also been reported in Europe and Japan, often in older males with underlying 72 
chronic liver diseases  (Lewis et al., 2010). In pregnant women, the proportion of 73 
fulminant cases can reach 25%, although these cases were only described for GT1 74 
strains circulating predominantly in developing countries (Smith, 2001).  75 
 76 
While Hepatitis E was originally considered to be endemic only in areas of Asia, Africa 77 
and Mexico (WHO, 2010), sporadic cases were recently observed in developed 78 
countries, including Europe. These were initially considered to be imported, however, 79 
enhanced Hepatitis E surveillance has detected an increasing number of non-travel 80 
associated infections (Dalton et al., 2008), e.g. in France (Nicand et al., 2009), in the 81 
United Kingdom (Ijaz et al., 2014) and in Germany (Robert Koch Institut, 2015). The 82 
exact transmission routes for autochthonous HEV cases remain unknown, but 83 
foodborne transmission was identified as an emerging concern (EFSA, 2011). 84 
Contaminated products mostly include pork products (e.g. pork pies, under-cooked or 85 
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raw pork meat and liver pate), but also deer meat, wild boar meat, offal, shellfish and 86 
some ethnic foods are described (Lewis et al., 2010). Few outbreak investigations have 87 
been performed so far. Some of them confirmed the role of specific pork items such as 88 
figatellu, a traditional dried pig liver sausage widely eaten in France and commonly 89 
consumed raw (Colson et al., 2010), and undercooked pig liver–based stuffing (Guillois 90 
et al., 2015).  91 
 92 
In Switzerland, no specific surveillance is in place and Hepatitis E is not a notifiable 93 
disease, therefore the exact number of diagnosed cases is not known (EDI, 2015). Few 94 
case reports confirmed that two autochthonous cases - including one acute case - with 95 
unknown exposure were diagnosed in the canton Geneva in 2004 (Sudre et al., 2005) 96 
and 12 acute autochthonous cases were diagnosed in the canton Vaud in 2013 (Hiroz 97 
et al., 2013). Recently, two acute cases were reported in the canton Nidwalden of a 98 
hunter who consumed deer and wild boar meat (Joller and Gaudenz, 2015), and in the 99 
canton Saint Gallen of a person who took part in a nature walk, during which wild, 100 
possibly contaminated herbs were collected and consumed (Sawatzki et al., 2015). One 101 
chronic case was also identified among a Swiss cohort of HIV patients (Kenfak-Foguena 102 
et al., 2011). However, Hepatitis E is likely to be underdiagnosed in Switzerland as the 103 
awareness for the disease is low among medical practitioners (Joller and Gaudenz, 104 
2015). The occurrence of HEV is probably widespread as shown by a seroprevalence 105 
study conducted among blood donors in the Vaud canton (Kaufmann et al., 2011); 106 
depending on the diagnostic test used, the seroprevalence was estimated to be 107 
between 4.2% and 21.8% (Schnegg et al., 2013).  108 
 109 
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No quantitative data about the occurrence or the load of HEV in food is currently 110 
available in Switzerland. The seroprevalence of Hepatitis E in slaughtered pigs was 111 
estimated to be 49% at animal levels and 60% at farm level (Wacheck et al., 2012). A 112 
recent study covering the period of 2006-2011 confirmed HEV seroprevalence to be 113 
58.1% in domestic pigs, and 12.5% in wild boars (Burri et al., 2014). The impact of this 114 
in terms of risk for the consumer of pork or wild boar is unknown. 115 
 116 
In 2011, EFSA recommended to develop a risk assessment framework for specific HEV-117 
commodity combinations and target populations, in order to identify specific data 118 
gaps, and to target research efforts (EFSA, 2011). In response to this recommendation 119 
we developed a population-based risk assessment framework for human Hepatitis E 120 
infection. More particularly, the specific study objectives were i) to assess the risk of 121 
hepatitis E from the consumption of pork and wild boar products, and ii) to estimate 122 
the overall burden of human hepatitis E in Switzerland. 123 
 124 
2. Material and Methods 125 
The quantitative risk assessment was carried out according to Codex Alimentarius 126 
Framework (Cac/Gl 63, 2007). Fig. 1 illustrates the framework of the risk assessment of 127 
hepatitis E infection by the consumption of pork and wild boar products.  128 
 129 
[Fig. 1] 130 
  131 
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2.1. Hazard identification 132 
HEV GT3 and GT4  are the genotypes considered as hazards in the present study, as 133 
foodborne transmission has been described for them (Berto et al., 2013; Borgen et al., 134 
2008; Colson et al., 2012, 2010; Pavio et al., 2014). Current diagnostic methods are 135 
based on PCR methodology (Jothikumar et al., 2006; Mokhtari et al., 2013; Szabo et al., 136 
2015; Ward et al., 2009). Accordingly, HEV RNA is the relevant unit of the hazard in the 137 
present analysis. It was assumed that products with high number of genome copies 138 
per gram (gc/g) were more likely to contain infectious HEV particles, potentially 139 
causing adverse health effect than those with lower ones. 140 
 141 
In terms of relevant pork products, these were selected using the recipes of traditional 142 
pork products provided by the specialist school for butchers 143 
(http://www.abzspiez.ch/). Pork products were included if they contained pork liver 144 
and/or pork meat, and excluded if only containing pork fat. Fifty-two traditional meat 145 
products were included, pork meat, pork liver and wild boar liver. Products were 146 
grouped based on liver and meat content into three categories. Category 1 consisted 147 
of products containing pork liver in different proportions but no pork meat. It included 148 
products sold raw and cooked before consumption, such as pork and wild boar liver, as 149 
well as pasteurized products such as different liver paté´s. Category 2 consisted of 150 
products containing different proportions of pork liver and meat. Some, such as a cold 151 
smoked liver sausage, denominated Saucisse au foie are sold raw, to be cooked before 152 
consumption, others are sold pasteurized, such as Paté de Campagne. Category 3 153 
included products containing pork meat but no liver, and which are either sold 154 
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pasteurized, such as ham, or sold raw to be cooked before consumption, such as pork 155 
meat.  156 
 157 
2.2. Exposure assessment 158 
 159 
2.2.1. Model frameworks 160 
HEV contamination prevalence and load were initially modelled separately and then 161 
combined in the exposure assessment. Recipes and transformation processes were 162 
collected and their impact on HEV load and prevalence was modelled. The effects of 163 
salting, marinating, smoking, drying and curing were considered negligible, as HEV RNA 164 
has been found in dried cured sausages (Colson et al., 2010; Di Bartolo et al., 2012; 165 
Pavio et al., 2014). Only heat treatment, such as pasteurization or home cooking 166 
before consumption, was retained in the model. To quantify the impact of heat 167 
treatment, data on the decimal reduction time (D-value) and/or the effect of different 168 
time-temperature combinations on HEV load measured by current PCR tests were 169 
required but not available. The effect of heat on HEV load was estimated based on the 170 
findings of Barnaud et al. (2012) as described below. A mixing effect was ascribed to 171 
the fact that meat and liver from different carcasses are likely to be used for the 172 
preparation of transformed products, whereby a decrease in HEV RNA load (i.e. 173 
concentration of potential infectivity) would be expected due to dilution.  174 
 175 
Finally, the level of HEV contamination at the point of consumption was estimated per 176 
serving of the specified pork product. An average serving size of 30 g was considered 177 
for sliced and spreadable pork products, and 150 g for large sausages (e.g. Boudin 178 
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Blanc, a sausage made of cooked meat and liver) and also for plain liver 179 
(www.lebensmittelwissen.de). Cross-contamination of meat products by HEV 180 
contaminated pork faeces, blood, liver, meat may occur at all steps along the 181 
production chain, but were considered to be minor contributors to the overall model 182 
outcome and therefore not considered further (Berto et al., 2012; Di Bartolo et al., 183 
2015).  184 
 185 
2.2.2. Parameter inputs 186 
 187 
HEV prevalence model 188 
To investigate the prevalence of HEV in pig livers (Pliver) with a precision of 5% and a 189 
confidence interval of 95%, 160 domestic pig livers originating from 40 herds were 190 
sampled at a main Swiss slaughterhouse representative of approximately 50% of the 191 
national pig slaughter volume. Sample size calculation was based on an expected HEV 192 
prevalence in pig livers at slaughter of 5% (Berto et al., 2012; Bouwknegt et al., 2007; 193 
Di Bartolo et al., 2012; Rose et al., 2011), a sensitivity of the diagnostic test of 0.9 and a 194 
specificity of 0.99 (Hepatitis E Virus Detection Kit, Thermo Fisher Scientific) and 195 
assuming an intra-cluster (i.e. intra-herd) correlation coefficient (ICC) of 0.2 (Dohoo et 196 
al., 2009). Samples were handled as described by Rose et al., (2011): small liver 197 
sections (2 cm x 1cm x 1cm) were cut from the left medial lobe of selected livers, 198 
immediately placed at 4°C, frozen and stored at -80°C until further analysis. Gloves and 199 
blades were changed between each liver to prevent any possible cross-contamination. 200 
HEV was detected by real time PCR test using a commercial kit (Hepatitis E Virus 201 
Detection Kit, Thermo Fisher Scientific) according to the protocol of the manufacture 202 
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on pools of four samples. Samples from positive pools were then tested individually, 203 
and the load of HEV in positive samples was estimated using the Hepatitis E 204 
quantification standard test (Thermo Fisher Scientific). 205 
 206 
The output of the prevalence model was the proportion of HEV contamination in the 207 
specified categories of products, estimated as follows: 208 
Pproduct =1-[(1-Pliver)(1- Pmeat)]       (Eq. 1) 209 
 210 
where Pproduct represents the prevalence of HEV RNA-contaminated specified pork 211 
products at the point of consumption. Pliver and Pmeat represent the prevalence of HEV 212 
RNA positive pork liver and meat at slaughter, respectively.  Pwildboar was used instead 213 
of Pliver to represent the prevalence of HEV contamination in wild boar liver. No data 214 
was available of the prevalence of HEV contaminated wild boar meat. The model 215 
parameters are shown in Table 1. 216 
 217 
Table 1 218 
Input parameters of the exposure assessment models of foodborne Hepatitis E and the 219 
Hepatitis E DALY model. 220 
 221 
  222 
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HEV Prevalence Model HEV Load Model DALY Model 
Parameter 
Prevalence 
Model 
Deterministic 
(number 
positive/ 
number 
tested) 
Probability 
distribution 
of input 
parameters 
References 
Prevalence 
Model 
Parameter 
Load Model 
Probability 
distributions 
and input 
parameters 
References 
Load 
Model 
Assumptions 
DALY Model 
Parameter 
DALY 
Model 
Outcome 
1 
Outcome 
2 Source 
HEV 
prevalence 
in pig liver 
(Pliver) 
0.034 
(136/4027) 
Beta (137, 
3892)* 
(Berto et 
al., 2012; 
Di Bartolo 
et al., 
2012; Rose 
et al., 
2011), own 
data 
Log HEV RNA 
concentration 
in liver (Cliver) 
Lognormal 
(6.11, 1.116) 
(Barnaud 
et al., 
2012; 
Leblanc et 
al., 2010; 
Pavio et 
al., 2014; 
Wilhelm et 
al., 2014; 
Yazaki et 
al., 2003) 
and own 
data 
mean = 
geometric 
mean of 
maximum 
HEV RNA 
loads, std = 
std of max 
loads 
Age at 
onset in 
male 
patients 
(years) 
Beta Pert 
(24, 57, 
93) 
Beta Pert 
(38, 68, 
88) 
Ticino 
data 
(own 
data) 
HEV 
prevalence 
in wild boar 
liver 
(Pwildboar) 
0.184 
(42/228) 
Beta (43, 
187) 
(Mesquita 
et al., 
2014; 
Schielke et 
al., 2009) 
Log HEV RNA 
load in pork 
meat/chops 
none 
(Leblanc et 
al., 2010; 
Wilhelm et 
al., 2014) 
Below 
threshold, 
assume 
“very low 
load” 
Age at 
onset in 
female 
patients 
(years) 
Beta Pert 
(32, 47, 
82) 
Beta Pert 
(34, 82, 
90) 
Ticino 
data 
(own 
data) 
HEV 
prevalence 
in pig meat 
(Pmeat) 
0.012 (9/765) Beta (10, 757) 
(Berto et 
al., 2012; 
Di Bartolo 
et al., 
2012; 
Leblanc et 
al., 2010; 
Wilhelm et 
al., 2014) 
Mixing effect 
(MixLoad) 
Pert (-3.237, 
1.071, 
4.372) 
(ANSES, 
2015; 
Leblanc et 
al., 2010; 
Pavio et 
al., 2014; 
Renou et 
al., 2014; 
Wilhelm et 
Composition 
of dried pork 
liver 
sausages: 
40% liver 
Outcome 
duration 
(years) 
Beta Pert 
(0.08, 
0.11, 
0.15) 
Beta Pert 
(0.08, 
0.11, 
0.15) 
(Kamar et 
al., 2012) 
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al., 2014) 
    
Heat 
reduction 
(HRload) 
Pert (2.282, 
2.609, 
2.935) 
(Barnaud 
et al., 
2012) 
Heating at 
68°C and 
71°C during 
5 min 
Age at 
death in 
male 
patients 
(years) 
Beta Pert 
(61, 70, 
80) 
Beta Pert 
(39, 67, 
68) 
Ticino 
data 
(own 
data) 
        
Age at 
death in 
female 
patients 
(years) 
-** 
Beta Pert 
(71, 82, 
83) 
Ticino 
data 
(own 
data) 
        Disability weight wi 
0.058 0.353 
(Havelaar 
et al., 
2012) 
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 223 
HEV load model 224 
The output of the HEV RNA load model was the concentration of HEV RNA throughout 225 
the different processing steps until the point of consumption. The concentration of 226 
HEV in the product at consumption (Cproduct), expressed as log genome copies per gram 227 
(gc/g): 228 
Cproduct = (L*Cliver) - MixLoad – HRload       (Eq. 2) 229 
 230 
Where Cliver represents the log HEV concentration in positive pig livers, modelled using 231 
own data and according to published maximum log HEV loads (Barnaud et al., 2012; 232 
Leblanc et al., 2010; Pavio et al., 2014; Wilhelm et al., 2014; Yazaki et al., 2003). No 233 
values of HEV RNA load of pork meat were available (Leblanc et al., 2010; Wilhelm et 234 
al., 2014). Products containing only pig meat but no liver were therefore considered to 235 
have loads below <103 gc/g, i.e. below PCR detection threshold (Leblanc et al., 2010; 236 
Wilhelm et al., 2014), and not further considered in the HEV load model. L represents 237 
the proportion of pork liver in the product. MixLoad and  HRload represent the log HEV 238 
RNA load reduction (gc/g) in the product due to mixing with other ingredients and due 239 
to heat processing (pasteurization or  cooking), respectively. Model parameters are 240 
shown in Table 1. 241 
 242 
The effect of mixing HEV contaminated with uncontaminated pork ingredients (MixLoad) 243 
on the HEV load of the final product was estimated by comparing the virus load 244 
expected according to the model with that observed in dried pork liver sausages at 245 
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retail (Pavio et al., 2014; Renou et al., 2014). It was assumed that dried liver sausages 246 
were composed of 40% pork liver.  247 
 248 
The effect of pasteurization on HEV RNA load (HRload) was modelled by a Pert 249 
distribution using information on the effect of heating HEV contaminated material 250 
during 5 minutes at 68°C and at 71°C (Barnaud et al., 2012).  The log HEV 251 
concentration per serving of specified product (Cserving), expressed as (gc/serving), was 252 
calculated: 253 
Cserving = Cproduct + log S       (Eq. 3) 254 
 255 
Where Cproduct represents the log HEV concentration per gram of the specified product 256 
(gc/g) and S represents the average serving size in gram (g) of the product.  257 
 258 
To quantify both exposure and load, two stochastic Monte Carlo risk assessment 259 
models were developed using the software @RISK for EXCEL version 6.2.0 (Palisade 260 
Corporation 2013). Latin hypercube sampling of the distributions was performed by 261 
10,000 iterations.  262 
 263 
2.3. Hazard characterization 264 
For the hazard characterization the prevalence and load models of the exposure 265 
assessment were combined. A dose-response relationship for oral exposure to 266 
hepatitis E virus was not available and therefore needed to be approximated. A 267 
threshold dose of 105 gc per serving was assumed to represent the minimum dose 268 
potentially resulting in infection by the oral route (AFFSA, 2009; Renou et al., 2014). 269 
FOOD-D-16-00375 submitted 23/03/2016  Revision 06 07 2016 
15 
 
This represents a value between the reported effective dosis of 104.68 gc/g (Renou et 270 
al., 2014) and an estimated 50% oral infectious dose of 105.5 genome equivalents 271 
(AFFSA, 2009). The proportion of infections resulting in acute disease and medical 272 
attention seeking is unknown (Aggarwal, 2011).  The probability that consumption of 273 
any random serving of pork product leads to acute illness (Pacute) was estimated: 274 
Pacute = Pproduct * Phi*Pinf*Pill       (Eq. 4) 275 
 276 
Where Pproduct is the probability of HEV contaminated specified pork product 277 
(Prevalence model, Eq. 1). Phi corresponds to the probability of the contaminated 278 
products containing HEV RNA levels >105 gc /serving, and was read off the distribution 279 
curve of the load model. Pinf is the probability of successful infections upon oral 280 
exposure to doses higher than the threshold. To reflect uncertainty and partially 281 
effective heat treatment, it was assumed that products containing pork liver and high 282 
HEV loads may, despite pasteurization or cooking, contain approximately 1% of 283 
infectious HEV (Pert 0.005, 0.01, 0.02). Pill is the probability of acute illness after 284 
infection in the susceptible population. The latter was modelled by a Pert distribution. 285 
The maximum value of 0.14 was derived from foodborne outbreaks, where only the 286 
index cases seeking medical attention (7/50) were considered (Colson et al., 2010; 287 
Guillois et al., 2015; Said et al., 2009). The minimum and most likely values for the 288 
probability of developing acute illness after infection were assumed to be 0.01 and 289 
0.05, respectively. Other outcomes, such as asymptomatic, mild clinical and chronic 290 
infection were not considered.  291 
 292 
2.4. Risk characterization  293 
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The expected number of acute illness cases caused by foodborne hepatitis E infection 294 
in Switzerland were estimated based on meat consumption data of 2012 (BAG, 2012) 295 
and on population demographics of 2014 (http://www.bfs.admin.ch/). In Switzerland, 296 
the average annual consumption of meat was of 51.98 kg per person, consisting of 297 
6.64 kg (14%) pork meat and of 16.84 kg (35.5%) of meat products such as charcuterie 298 
and sausages (Proviande, 2013). As consumption data for specific pork products was 299 
not available, we assumed that the list of 52 pork products (i.e. excluding pork meat) 300 
included in our study was comprehensive, and that every adult inhabitant consumed 301 
all the 50 selected Swiss traditional pork products, as well as pork liver and wild boar 302 
liver, in equal proportions, up to the average of 16.84 kg per year, resulting in an 303 
average (rounded) annual consumption of 300 g of each product. The risk 304 
characterization focussed exclusively on products containing pork liver.  305 
 306 
Data on population demographics in Switzerland were derived from the interactive 307 
database STAT-TAB of the Swiss Federal Statistical Office (http://www.bfs.admin.ch/). 308 
The target population of pork consuming adult permanent residents was calculated as  309 
6,113,400, i.e. excluding 3% of vegetarians (http://www.swissveg.ch) as well as adult 310 
muslim residents (STAT-TAB). It was assumed that seropositivity confers immunity to 311 
HEV reinfection (Arends et al., 2014; Said et al., 2009). The susceptible population 312 
(Pop) corrected by the HEV seroprevalence, which was modelled as Uniform 313 
distribution (0.04, 0.22) (Schnegg et al., 2013). The total number of expected cases of 314 
acute hepatitis E  per year in Switzerland was therefore: 315 
Ncases = Pop * Pacute * ∑i Nserv(i)      (Eq. 5) 316 
 317 
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Where Pacute is the probability that consumption of any random serving of pork product 318 
leads to acute illness (Eq. 4), Pop is the susceptible adult permanent resident 319 
population and Nserv(i) is the number of servings of each product (i) consumed annually. 320 
 321 
Two scenarios were created to estimate the number of annual cases due to foodborne 322 
hepatitis E. Scenario 1 assumed that around 1% of infectious HEV (Pinf = Pert 0.005, 323 
0.01, 0.02) may occur in all pork liver containing products, including those pasteurized 324 
before retail. Scenario 2 assumed that 1% of infectious HEV (Pinf = Pert 0.005, 0.01, 325 
0.02) is only observed in “high risk products”, which are those sold raw and 326 
inadequately cooked before consumption. 327 
 328 
Sensitivity analysis was conducted in @RISK for EXCEL version 6.2.0 to identify the 329 
model input parameters mostly influencing the outcomes of the risk characterization. 330 
 331 
2.5. Estimation of the burden of hepatitis E 332 
The burden of hepatitis E in Switzerland was estimated in terms of Disability Adjusted 333 
Life Years (DALY) (Murray et al., 2012). DALY were calculated from the sum of the 334 
number of years of life lost due to the mortality of hepatitis E (YLL) and the number of 335 
years lived with a disability (YLD): 336 
DALY = YLL + YLD         (Eq. 6) 337 
with  YLL =  ∑i di *ei         (Eq. 7) 338 
 339 
where di corresponds to the number of fatal cases due to health outcome i and ei to 340 
the expected individual live span at the age of death, and: 341 
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YLD = ∑i ni *ti *wi         (Eq. 8) 342 
 343 
where ni represents the number of cases with health outcome i, ti the duration of the 344 
health outcome i (in years) and wi the disability weight assigned to health outcome i 345 
that ranges between 0 (perfect health) and 1 (equivalent to death). 346 
 347 
Because hepatitis E is not notifiable in Switzerland, the 33 major accredited diagnostic 348 
laboratories (i.e. cantonal hospital laboratories or private laboratories) were contacted 349 
to provide data (Federal Office of Public Health, 2015). No authorization was required 350 
as only anonymous, non-genetic data were requested, with no possibility to assign the 351 
data to a specific person (Swiss Federal Council, 2011). Six laboratories confirmed that 352 
they were performing hepatitis E diagnosis, while 13 laboratories were transferring 353 
their samples to bigger laboratories for diagnosis. Thus, DALY calculations were 354 
performed using the data from two hospitals, located in the canton of Ticino and 355 
believed to centralize all hepatitis E cases from the Ticino reference population. 356 
 357 
Hepatitis E cases were defined as patients showing alanine aminotransferase (ALT) and 358 
aspartate aminotransferase (AST) elevation and hepatitis E IgG or IgM positive 359 
serology. As only acute hepatitis E cases (i.e. self-limited hepatitis E with ALT and AST 360 
elevation during 4 to 6 weeks) had been diagnosed at the two Ticino hospitals, chronic 361 
cases were excluded from further DALY calculations. PCR testing was also not 362 
considered as it is not performed systematically in Switzerland, and because the short 363 
RNA detection window might lead to false negative results (Kamar et al., 2014). Total 364 
number of cases was collected for the period from January 1st, 2010 to September 1st, 365 
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2015. Laboratory and clinical records were consulted by hospital personnel in order to 366 
collect, for each individual case, the diagnostic year, IgG and IgM serological test 367 
outcomes, patient sex and age at the moment of diagnosis, possible route of infection 368 
(i.e. travel- or meat consumption related), presence of underlying chronic disease or 369 
immunosuppression, and hepatitis E outcome. Data on the serological test´s diagnostic 370 
sensitivity and specificity were also collected for the period under study. 371 
 372 
In accordance with Havelaar et al. (2012), two disease outcomes were considered: 1) 373 
hepatitis with general practitioner (GP) visit but no hospitalization (i.e. mild hepatitis E) 374 
and 2) hepatitis with hospitalization (i.e. severe hepatitis E). Cases not visiting their GP 375 
were not considered. Annual DALY estimates were calculated for 2010-2015. Certain 376 
model parameters changed over the years, namely: the number of fatal cases and the 377 
number of cases with outcomes 1 and 2. Other parameters were fixed over the years 378 
as described in Table 1. The canton Ticino population data by sex and age categories, 379 
as well as life expectancy data were obtained from the Swiss national statistics 380 
(http://www.bfs.admin.ch/). DALY calculations were conducted in R 3.0.1 using the 381 
DALY package. No age weighting or discount rate was applied. 382 
  383 
 384 
3. Results 385 
 386 
3.1. Exposure assessment 387 
Out of 160 pig livers of 40 different Swiss fattening farms, two yielded a positive result, 388 
with a HEV load of  102.033 and  104.047gc/g. The prevalence was therefore established to be 389 
FOOD-D-16-00375 submitted 23/03/2016  Revision 06 07 2016 
20 
 
1.25 % (95% CI 0.3%; 4.4%). The highest prevalence of HEV contamination was 390 
estimated as 18.38% (95% CI 13.93%; 23.97%) for wild boar liver or products thereof 391 
(category 1). The HEV prevalence of other category 1 products consisting of pork liver 392 
was estimated as 3.37% (95% CI 2.86%; 3.98%) (Appendix Table A. 1. and Fig. A. 1.). 393 
Products containing pork meat and pork liver (category 2) and those containing pork 394 
meat but no liver (category 3), had an estimated HEV prevalence of 4.60% (95% CI 395 
3.80%; 5.72%) and 1.19% (95% CI 0.62%; 2.21%), respectively. 396 
 397 
HEV contamination load was estimated only for products containing pork liver 398 
(categories 1 and 2), (Appendix Table A. 1. and Fig. A. 2.). Eight meat products plus 399 
plain liver were retained in the model. The highest estimated log HEV contamination 400 
level was 3.5 gc/g (95% CI 1.6; 6.0) for cooked pork liver. The lowest expected log HEV 401 
load of 1.6 gc/g was estimated to occur in Saucisse au Foie (95% CI -2.0; 5.0). The log 402 
HEV load of the remaining products, which include diverse liver paté´s and terrines 403 
ranged from 2.3 (95% CI -1.2; 5.7) in Paté au foie to 1.9 (95% CI -1.7; 5.3) in 404 
Hausmacherleberwurst. 405 
 406 
3.2. Hazard characterisation   407 
The estimated overall probabilities of any random serving of different products being 408 
contaminated above the hypothetical oral infection threshold of 105 gc in pasteurized 409 
products ranged from a maximum of 1.33% in a 150g serving of Leberwurst Boudin 410 
Blanc, to 0.51% (95% CI 0.43%; 0.60%) in Hausmacherleberwurst, a pasteurized 411 
spreadable liver paté (Appendix Table A. 1. and Fig. A. 3.). In the “high risk” products, 412 
which are those sold raw to be cooked before consumption, the estimated 413 
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probabilities of high load HEV contamination were 2.40% (95%CI 2.04%; 2.83%) in 414 
random servings of 150g of pork liver, and 0.96% (95% 0.79%; 1.17%) in 150g of 415 
Saucisse au foie. 416 
The most likely number of cases of acute illness arising per 100,000 random servings of 417 
the specified pork liver-containing products ranged between a maximum of 1.10 (95% 418 
CI 0.43; 3.36) in pork liver and a minimum of 0.27 (95% CI 0.09; 0.71) in 419 
Hausmacherleberwurst (Appendix Table A. 1. and Fig. A. 4.). 420 
 421 
3.3. Risk characterisation  422 
As the estimated average annual consumption of individual pork products was 423 
estimated as (rounded) 300 g per person, we considered an annual consumption of 424 
two servings per person for products with serving sizes of 150 g (Saucisse au Foie, 425 
Leberwurst Boudin blanc and pork liver) and ten servings of each product of 30 g 426 
serving size. 427 
 428 
The most likely annual number of foodborne cases of hepatitis E per year in 429 
Switzerland according to scenario 1, was estimated to be 1,481 (95% CI 552; 4,488) 430 
(Appendix Table A. 1. and Fig. A. 5.). Of these, the consumption of Terrine du Chef and 431 
Paté de Campagne, both pasteurized products, was estimated to result in the highest 432 
number of annual cases (220, 95% CI 83; 658). All other products contributed less to 433 
the annual number of acute hepatitis E cases. Scenario 2 took into consideration only 434 
non-pasteurized products, i.e. those sold raw and potentially inadequately cooked by 435 
the consumer. According to this scenario, pig liver and Saucisse au foie were 436 
considered such “high risk products”, and estimated to result in 129 (95% CI 46; 355) 437 
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and 47 (95% CI 18; 143) annual cases of hepatitis E, respectively. Thus, the total annual 438 
number of foodborne hepatitis E cases according to scenario 2 was estimated as 176 439 
(95% CI 64; 498). 440 
 441 
Sensitivity analysis showed that the estimated number of hepatitis E cases per year in 442 
Switzerland was mostly influenced by the proportion of acute illness upon infection 443 
(Pill), the proportion of successful infections upon oral exposure to high HEV doses 444 
(Pinf), the prevalence of HEV in pig livers, HEV seroprevalence in the human population 445 
and HEV prevalence in pork meat (Appendix Table A. 2.). 446 
 447 
3.4. Estimated burden from Hepatitis E in the canton Ticino of Switzerland 448 
A total of 119 hepatitis E cases were diagnosed at the two hospitals of the canton 449 
Ticino between January 1st, 2010 and September 1st, 2015, among which 35 required 450 
hospitalization and 9 had a fatal outcome (Appendix Table A. 3.). Cases were mostly 451 
observed in males (68%) at a median age of 57 years old for cases visiting their GP and 452 
68 years old for hospitalized cases. 453 
 454 
The number of diagnosed cases substantially increased between 2012 (n=3 cases) and 455 
2015 (n=51 cases for the 8-month period), leading to an increase in mean DALY per 456 
year and per 100,000 inhabitants (Table 2).  457 
 458 
  459 
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Table 2 460 
Burden of Hepatitis E in the canton Ticino between 2010 and 2015. 461 
Year 
Mean YLL per 
year 
(CI 95%)* 
Mean YLD per 
year 
(CI 95%) 
Mean DALY 
per year 
(CI 95%) 
Mean DALY 
per 100,000 
inhabitants 
(CI 95%) 
2010 10.30 (5.09; 15.47) 
0.06 
(0.05; 0.07) 
10.36 
(5.14; 15.52) 
3.10 
(1.54; 4.65) 
2011 0.00 (0.00; 0.00) 
0.07 
(0.06; 0.07) 
0.07 
(0.06; 0.07) 
0.02 
(0.02; 0.02) 
2012 0.00 (0.00; 0.00) 
0.02 
(0.02; 0.02) 
0.02 
(0.02; 0.02) 
0.01 
(0.01; 0.01) 
2013 17.97 (12.70; 27.80) 
0.45 
(0.38; 0.52) 
18.41  
(13.17; 28.26) 
5.31 
(3.80; 8.15) 
2014 40.54 (29.09; 60.38) 
0.59 
(0.51; 0.67) 
41.12  
(29.68; 60.96) 
11.74 
(8.47; 17.40) 
2015 (up to 
01/09/15) 
170.04 
(165.22; 
177.80) 
0.73 
(0.63; 0.82) 
170.77  
(166.02; 
178.55) 
48.74 
(47.39; 50.96) 
*95% Credibility interval 462 
 463 
 464 
4. Discussion 465 
The exposure assessment showed that HEV prevalence in Swiss pork livers was slightly 466 
lower, but still within the range of prevalence described in other European countries 467 
(Berto et al., 2012; Bouwknegt et al., 2007; Di Bartolo et al., 2012). At retail, we 468 
estimated that < 6% of the products containing pork liver (categories 1 and 2), and < 469 
3% of the products containing pork meat could be contaminated with HEV genetic 470 
material.  These values are below the range of 6% to 22% recently described in pork 471 
sausages with and without liver in Europe (Berto et al., 2012; Di Bartolo et al., 2015, 472 
2012; Szabo et al., 2015). Regarding viral load in pork products at retail, our estimates 473 
of log HEV load at consumption, ranging between 3.5 (95% CI 1.6; 6.0) and 1.6 (95% CI 474 
2.0; 5.0) gc/g, were slightly lower than those described in dried and fresh liver 475 
FOOD-D-16-00375 submitted 23/03/2016  Revision 06 07 2016 
24 
 
sausages, where log loads of up to 6 were measured (Colson et al., 2010; Pavio et al., 476 
2014). These discrepancies between estimated and published HEV prevalence and load 477 
values in pork products may be explained by the input parameters of the prevalence 478 
model, as HEV prevalence data may vary geographically according to pig husbandry 479 
practices. Further, the sensitivity of current PCR methodologies varies and is 480 
influenced by DNA extraction methods; and current PCR methods are unable to 481 
discriminate between infectious and inactivated HEV particles (Baylis et al., 2011; 482 
Jothikumar et al., 2006; Mokhtari et al., 2013; Szabo et al., 2015; Ward et al., 2009). 483 
This may over- or underestimate HEV prevalence and load in pork products and may 484 
explain the discrepancy between our model´s results and those of other studies (Berto 485 
et al., 2012; Colson et al., 2010; Di Bartolo et al., 2015, 2012; Szabo et al., 2015). To 486 
improve accuracy of data for risk assessments, internationally standardized HEV PCR 487 
assays are needed, that specifically target infectious virus (Baylis et al., 2013, 2011; 488 
EFSA, 2011; Szabo et al., 2015). A promising PCR assay which targets amplification of 489 
RNA of intact viral particles has been described recently (Schielke et al., 2011). The 490 
underlying assumption is that only intact viral particles are infectious, whereas viral 491 
RNA fragments that may be amplified by PCR are not. This assay however requires 492 
further validation regarding the correlation of PCR signals with HEV infectivity. Further 493 
applications of such assays would be to assess the effect of heat treatment (D-values) 494 
and other processing steps on HEV prevalence and load in meat products. 495 
 496 
The hazard characterization was based on major assumptions related to the dose-497 
response relationship. The proportion of consumers getting successfully infected after 498 
oral exposure (Pinf) to a given HEV threshold dose (105 g.c.), and the proportion of 499 
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those infected that develop severe acute illness (Pill) are unknown for foodborne 500 
Hepatitis E (EFSA, 2011). Model parameters were approximated from previously 501 
published data (AFFSA, 2009; Colson et al., 2010; Guillois et al., 2015; Renou et al., 502 
2014; Said et al., 2009). Hepatitis E dose-response is very likely to vary individually, 503 
especially if co-morbidities such as pre-existing liver disease are present (EFSA, 2011; 504 
Kamar et al., 2012). The proportion of successful infections upon oral exposure to high 505 
HEV doses and the proportion of acute illness upon infection should be better 506 
informed as these mostly influence the model outcomes. 507 
 508 
The risk characterization was based on average meat consumption and population 509 
demographics. However, individual tastes, cooking habits, gender, socio-economic 510 
background and other factors are very likely to influence meat consumption and hence 511 
the risk of contracting HEV infection and of developing acute disease (EFSA, 2011; 512 
Kamar et al., 2012). These should be included in future risk assessments. 513 
 514 
The risk of foodborne hepatitis E was characterized initially (scenario 1) considering all 515 
pork products containing liver, regardless of whether they were pasteurized, resulting 516 
in a most likely annual number of 1,481 cases (95% CI 552; 4,488), or an incidence rate 517 
of 16.87 (95% CI 7.54; 58.94) per 100,000 inhabitants.  Scenario 2 assumed that HEV 518 
was totally inactivated in pasteurized products and the model only included “high risk 519 
liver products”, resulting in a total of 176 (95% CI 64, 498) cases, or an incidence rate 520 
of 2.17 (95% CI 0.97, 7.60) per 100,000 inhabitants (Appendix Table A. 1. and Fig. A. 6.).  521 
Repeated exposure was not considered; patients in the incubation period (estimated 522 
to be 40 days on average) (WHO, 2015) were not removed from the population at risk.  523 
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 524 
In 2014, the incidence rate of hepatitis E in the canton of Ticino was calculated to be 525 
12 cases per 100,000 inhabitants (Appendix Table A. 3.). Despite being clearly below 526 
this value, we consider the estimate of the Scenario 2 to be more realistic than that of 527 
Scenario 1. Other food items such as partially uncooked pork, wild boar and deer meat, 528 
various types of sausages including fermented sausages may account for the remaining 529 
difference of observed cases (Di Bartolo et al., 2012; Schielke et al., 2009; Tei et al., 530 
2003). These products were not included in our risk assessment due to missing data 531 
and a lack of evidence of outbreaks associated with meat (Colson et al., 2010; Guillois 532 
et al., 2015; Renou et al., 2014).  533 
 534 
Also, cases recorded in the canton Ticino included all hepatitis E cases, with almost no 535 
information about possible exposure routes. Source attribution of Swiss hepatitis E 536 
cases needs to be further explored. An expert elicitation conducted in the Netherlands 537 
concluded that on average, hepatitis E was transmitted at 14% by food, 25%  by the 538 
environment, 8% via human to human transmission, 11% from direct contact with 539 
animals and 43% during foreign travel by any of the above pathways (Havelaar et al., 540 
2008). Yet, this elicitation was based on only two experts, and confidence intervals 541 
were broad. A study conducted in the canton Zurich of Switzerland showed no 542 
increased risk of HEV infection in workers exposed to sewage (Jeggli, 2004), and no 543 
HEV was detected in effluent samples from Zurich water treatment plants (Masclaux et 544 
al., 2013). Moreover, using sewage sludge from water treatment plant as fertilizer in 545 
agriculture is banned in Switzerland since 2006 (Swiss Federal Office for the 546 
Environment, 2006). So transmission from the environment seems very unlikely.  547 
FOOD-D-16-00375 submitted 23/03/2016  Revision 06 07 2016 
27 
 
 548 
The hypothesis of a transmission by direct contact with animals is likely among certain 549 
occupational groups such as pig veterinarians (Bouwknegt et al., 2008; Meng et al., 550 
2002), pig farmers (Christensen et al., 2014; Galiana et al., 2008) and abattoir 551 
personnel (Vulcano et al., 2007). However to our knowledge, no study has shown that 552 
the occurrence of symptomatic cases was more frequent in these groups. Direct 553 
human-to-human transmission could also occur via blood transfusion in Switzerland, as 554 
4.2% to 21.8% of blood donors in the canton Vaud were shown to be IgG seropositive 555 
(Schnegg et al., 2013). However, the proportion of seropositive donors carrying HEV in 556 
their blood is unknown. More detailed investigation of cases would help rank the 557 
relative importance of the different transmission pathways, and support the 558 
prioritization of future preventive measures. 559 
 560 
The study of the burden of hepatitis E in Switzerland highlighted a substantial increase 561 
in mean DALY between 2012 and 2015; a recent increase in Hepatitis E incidence was 562 
also described in other European countries, e.g. France (Lhomme et al., 2015), 563 
Germany (Robert Koch Institut, 2015) and England (PHE, 2015). We estimated 564 
Hepatitis E burden in Ticino for 2013 to be 5.31 (95% CI 3.80, 8.15) per 100,000 565 
inhabitants in Ticino. For the same year, the burden of hepatitis A, human tuberculosis 566 
and diarrheal diseases in Switzerland was estimated to be 4.07 (95% CI 2.59, 5.94), 567 
16.35 (95% CI 13.86, 20.50) and 25.02 (95% CI 20.79, 29.91) per 100,000 inhabitants, 568 
respectively (IHME, 2015). Years of life lost (YLL) was the major contributor to the total 569 
hepatitis E burden; this is related to the acute clinical presentation of the disease.  570 
 571 
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However, in accordance with Kamar et al. (2012),  several reasons could have led to  572 
underestimating the burden of hepatitis E in Switzerland (Kamar et al., 2012). First, 573 
Swiss medical practitioners appear to be little aware of the disease (Joller and 574 
Gaudenz, 2015). Yet, the situation has improved in the recent years, as demonstrated 575 
by the increasing demand for hepatitis E serology  testing (Lausanne University 576 
Hospital, Division of Immunology and Allergy, personal communication). Additionally, 577 
acute hepatitis E due to HEV GT 3 was shown to be  578 
misdiagnosed; it was mistaken for drug-induced liver injury in six (13%) of 47 patients 579 
in the UK (Dalton et al., 2007) and nine (3%) of 318 cases in the US (Davern et al., 580 
2011). The fact that the present study did not include cases not visiting their GP and 581 
chronic cases could also have resulted in underestimating the total burden of hepatitis 582 
E, but the impact of these cases was considered to be very low.  583 
 584 
DALY calculations were based on data from a single canton representing 4.3% of the 585 
Swiss population in 2014, as no access to hepatitis E patients’ data was available in 586 
other cantons. Making hepatitis E a notifiable disease in Switzerland would certainly 587 
help get a better estimate of the national burden.  Extrapolations of Ticino DALY 588 
estimates to other cantons should be made with caution, as populations from other 589 
cantons might have other food consumptions or travel habits.  590 
 591 
We conclude that the burden of hepatitis E is low in Switzerland but an apparent 592 
increasing trend deserves attention. Source attribution would allow assessing the 593 
importance of foodborne exposure compared to other exposure routes, yet, the 594 
relative contribution of meat consumption is expected to remain non-negligible. Pork 595 
FOOD-D-16-00375 submitted 23/03/2016  Revision 06 07 2016 
29 
 
and wild boar products containing liver and sold raw were identified as the highest-risk 596 
products. Future risk management options might include providing information to the 597 
consumers. Making hepatitis E a notifiable disease is a requirement for further health 598 
impact assessments. In accordance with Bijkerk et al. (2015), the workload of case 599 
reporting programmes needs to be balanced against expected public health benefits. 600 
 601 
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APPENDIX A – Supporting material 906 
Table A. 1. 907 
Risk assessment for foodborne Hepatitis E: Results of the exposure assessment for Swiss traditional pork products (mode and 95% CI). 908 
 909 
PRODUCT 
CATEGORY 
Pork 
liver 
content 
PRODUCT*)  
(serving size) 
HEV RNA 
prevalence (%) 
(2.5th and 97.5th 
percentiles = 
95% CI) 
HEV RNA load (log 
gc/g) 
(2.5th and 97.5th 
percentiles = 95% CI) 
Probability (%) 
random serving HEV 
load >105gc 
(2.5th and 97.5th 
percentiles = 95% CI) 
Hazard 
characterization 
(Number of 
cases/100,000 
servings) 
Risk 
characterizati
on 
(Number of 
cases per year 
in 
Switzerland) 
Incidence rate 
per 100,000 
inhabitants 
(2.5th and 
97.5th 
percentiles = 
95% CI) 
1-  
Pork liver 
(n=6) 
100% Pork liver (150g) 3.37 (2.86, 3.98) 3.45 (1.59, 5.97) 2.40 (2.04, 2.83) 1.10 (0.43, 3.36) 129 (46, 355) 1.93 (0.69, 
5.41) 
100% Wild boar liver (150g) 18.38 (13.93, 
23.97) 
Likely similar to pork, 
(no load info 
available) 
Not determined Not determined Not 
determined 
Not 
determined 
30% Pâté au foie (Grundbrät) 
(30g) 
3.37 (2.86, 3.98) 
2.34 (-1.23, 5.73) 
0.73 (0.63, 0.87) 0.39 (0.13, 1.03) 199 (70, 546) 2.96 (1.07, 
8.32) 
25% Streichleberwurst (30g) 3.37 (2.86, 3.98) 2.26 (-1.31, 5.65) 0.70 (0.59, 0.82) 0.37 (0.12, 0.98) 188 (66, 517) 2.8 (1.01, 7.87) 
15% Geflügelfleischterrine 
(30g) 
3.37 (2.86, 3.98) 2.04 (-1.53, 5.43) 0.59 (0.50, 0.69) 0.31 (0.10, 0.82) 158 (56, 434) 2.35 (0.85, 
6.61) 
10% Hausmacherleberwurst 
(30g) 
3.37 (2.86, 3.98) 1.86 (-1.71, 5.26) 
 
0.51 (0.43, 0.60) 0.27 (0.09, 0.71) 136 (48, 374) 2.03 (0.73, 
5.70) 
2-  
Pork liver 
and meat 
(n=4) 
20% Pâté de Campagne (30g) 4.60 (3.80, 5.72) 2.16 (-1.41, 5.56) 0.88 (0.72, 1.09) 0.36 (0.16, 1.23) 219 (83, 658) 3.87 (1.26, 
10.08) 
20% Terrine du Chef (30g) 4.60 (3.80, 5.72) 2.16 (-1.41, 5.56) 0.88 (0.72, 1.08) 0.36 (0.16, 1.23) 220 (83, 658) 3.87 (1.26, 
10.08) 
15% Leberwurst - Boudin blanc 
(150g) 
4.60 (3.80, 5.72) 2.04 (-1.53, 5.43) 1.33 (1.09, 1.64) 0.54 (0.24, 1.85) 66 (25, 198) 1.17 (0.38, 
3.04) 
5% Saucisse au foie (150g) 4.60 (3.80, 5.72) 1.56 (-2,01, 4.96) 0.96 (0.79, 1.17) 0.38 (0.17, 1.33) 47 (18, 143) 0.84 (0.27, 
2.19) 
3-  
Pork meat 
(n=43) 
 
0% Pork meat 1.19 (0.62, 2.21) Not determined, 
likely <1 
Not determined Not determined Not 
determined 
Not 
determined 
0% Saucisse aux choux 
(Kabiswurst), Saucisson, 
Zwiebelmettwurst, 
1.19 (0.62, 2.21) 
 
Not determined, 
likely <1 
Not determined Not determined Not 
determined 
Not 
determined 
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Schweizer Salami, Salami 
nach Bauernart, 
Knoblauchwurst, Salsiz, 
Rauchwurst, Bündner 
Beinwurst, 
Bauernschüblig, Walliser 
Hauswurst, Rauchsalami, 
Saucisse d‘Ajoie, Pantli, 
Alpenklubler, 
Touristenwurst,Schweinsbr
atwurst, Luganighe, 
Zampone, Frankfurterli, 
Cotechini, Longeole, 
Engadiner, Glarner 
Kälberwurst, Hallauer 
Schinkenwurst, 
Schweinswurst, Berner 
Zungenwurst, Brianzola, 
Bierwurst, Emmentaler, 
Fleischkäse, Kümmelwurst, 
Lyoner (Aufschnittbrät), 
Tessiner Terrine, 
Schützenwurst, 
Frauenfelder Salzissen, 
Kalbsbratwurst, Cervelas, 
Knacker, St. Galler 
Kalbsbratwurst, St. Galler 
Stumpen, St. Galler 
Schüblig, Wienerli 
*) Based on http://www.abzspiez.ch/ 910 
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 911 
[Fig. A. 1.] 912 
 913 
[Fig. A. 2.] 914 
 915 
[Fig. A. 3.] 916 
 917 
[Fig. A. 4.] 918 
 919 
[Fig. A. 5.] 920 
 921 
[Fig. A. 6.] 922 
  923 
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Table A. 2. 924 
Sensitivity analyses of the hepatitis E foodborne risk assessment: Regression coefficients. 925 
 Parameter Pig 
Liver_coo
ked 
 
Pâté au 
foie 
(Grundbrä
t) 
Streich-
leberwurst 
 
Pâté de 
campagne 
Terrine 
du Chef 
Leberwurst 
Boudin blanc 
Geflügel-
fleisch-
terrine 
Hausmacher-
leberwurst 
Saucisse 
au 
foie_cooke
d 
 
LOAD MODEL 
HEV RNA load pig liver at 
slaughter 3.91 3.89 3.89 3.89 3.89 3.89 3.89 3.89 3.89 
Pasteurization effect 0.45 0.45 0.45 0.45 0.45 0.45 0.45 0.45 0.45 
Mixing effect  n/a 4.84 4.84 4.84 4.84 4.84 4.84 4.84 4.84 
 
 
 
WHOLE 
MODEL (Risk 
characterizati
on) 
Proportion acute 
illness(Pill) 
  225.73      347.16      328.14      414.64    414.64      125.04      275.82      237.78        89.88    
Proportion of exposed 
getting infected (Pinf)   140.01      215.33      203.53      256.81    256.81        77.45      171.08      147.49        55.67    
Pig LIVER / HEV 
prevalence     52.20        80.28        75.88        69.31    69.31        20.90        63.78        54.98        15.02    
HEV Seroprevalence 
(Schnegg 2013)     33.00        50.75        47.97        61.18    61.18        18.45        40.32        34.76        13.26    
Pig MEAT / HEV 
prevalence    n/d     n/d     n/d      85,63    85,63        25.82       n/d     n/d      18.56    
 926 
 927 
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Table A. 3. 928 
Distribution of Hepatitis E cases in the Swiss canton of Ticino per year, sex and outcomes. 929 
    Outcome 1 (hepatitis + GP visit) Outcome 2 (hepatitis + hospitalization) 
   
Number 
of cases 
Number 
of deaths 
Incidence rate 
(cases per 
100,000 
inhabitants) 
Mortality rate 
(deaths per 
100,000 
inhabitants) 
Number 
of cases 
Number 
of deaths 
Incidence 
rate (cases 
per 100 000 
inhabitants) 
Mortality 
rate (deaths 
per 100 000 
inhabitants) 
2010 Male 8 1 4.942 0.618 0 0 0.000 0.000 Female 1 0 0.582 0.000 0 0 0.000 0.000 
2011 Male 2 0 1.224 0.000 0 0 0.000 0.000 Female 2 0 1.153 0.000 1 0 0.577 0.000 
2012 Male 1 0 0.603 0.000 0 0 0.000 0.000 Female 2 0 1.138 0.000 0 0 0.000 0.000 
2013 Male 4 0 2.412 0.000 9 1 5.426 0.603 Female 4 0 2.277 0.000 1 0 0.569 0.000 
2014 Male 14 0 8.210 0.000 7 2 4.105 1.173 Female 7 0 3.895 0.000 5 1 2.782 0.556 
2015 (up 
to 
01/09/15) 
Male 29 2 17.007 1.173 7 0 4.105 0.000 
Female 10 0 5.565 0.000 5 2 2.782 1.113 
 930 
One female patient was pregnant at the time of diagnostic; she recovered after hospitalization. Twelve patients had underlying chronic liver 931 
diseases (e.g. alcoholic hepatitis, drug-induced hepatitis, hepatitis C or A) and 14 patients had no previous history of liver affections; the 932 
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information was missing for the remaining patients. Similarly, only sparse data was available on possible sources of infections. Eight patients 933 
had not been abroad in the recent months, whereas six patients had; however, the assumption of a travel-related infection could not be 934 
confirmed. Four patients reported regularly consuming different types of pork-products, such as fermented, cured or dried sausages, as well as 935 
deer and wildboar meat, but no proper investigation was conducted to confirm foodborne infections. No information on food consumption 936 
habits was available for the other patients.  937 
